U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 17

1.
Full record GDS4053

Postmenopausal estrogen receptor α-positive breast tumor with PIK3CA mutation

Analysis of estrogen receptor α-positive (ERα+) breast tumors with phosphatidylinositol 3-kinase catalytic subunit (PIK3CA) mutation. PIK3CA mutations have been observed in 30% to 40% of ERα-positive breast tumors. Results provide insight into the role of PIK3CA mutations in breast tumorigenesis.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 genotype/variation sets
Platform:
GPL570
Series:
GSE22035
43 Samples
Download data: CEL
2.

Gene expression data in estrogen receptor alpha positive breast tumors with and without PIK3CA mutations.

(Submitter supplied) PI3K/AKT pathway plays one of pivotal roles in breast cancer development and maintenance. PIK3CA, coding PIK3 catalytic subunit, is the oncogene which shows the high frequency of gain-of-function mutations leading to the PI3K/AKT pathway activation in breast cancer. In particular in the ERα-positive breast tumors PIK3CA mutations have been observed in 30% to 40%. However, genes expressed in connection to the pathway activation in breast tumorigenesis remain largely unknown. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4053
Platform:
GPL570
43 Samples
Download data: CEL
Series
Accession:
GSE22035
ID:
200022035
3.

AKT Isoform Specificity Downstream of PIK3CA Mutation Impacts Estradiol and PI3K Inhibitor Response in Breast Cancer Cells

(Submitter supplied) Background: PIK3CA mutations are observed in >30% of breast cancers, which are more common in estrogen receptor (ERα)-positive breast cancer compared with ERα-negative breast cancer. AKT1, 2, and 3 isoforms, major isoforms downstream of PI3K, modulate ERα activity. It is unknown whether PIK3CA mutation leads to preferential activation of specific AKT isoforms with an ability to modulate ERα function. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
24 Samples
Download data: TXT
Series
Accession:
GSE60759
ID:
200060759
4.

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

(Submitter supplied) Background: Estrogen receptor positive (ER+) breast cancers (BC) are heterogeneous with regard to their clinical behavior and response to therapies. The ER is currently the best predictor of response to the anti-estrogen agent tamoxifen, yet up to 30-40% of ER+BC will relapse despite tamoxifen treatment. New prognostic biomarkers and further biological understanding of tamoxifen resistance are required. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
77 Samples
Download data: CEL, RDATA, TXT
Series
Accession:
GSE9195
ID:
200009195
5.

Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade

(Submitter supplied) Purpose: A number of microarray studies have reported distinct molecular profiles of breast cancers (BC): basal-like, ErbB2-like and two to three luminal-like subtypes. These were associated with different clinical outcomes. However, although the basal and the ErbB2 subtypes are repeatedly recognized, identification of estrogen receptor (ER)-positive subtypes has been inconsistent. Refinement of their molecular definition is therefore needed. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL96 GPL97 GPL570
741 Samples
Download data: CEL, RDATA, TXT
Series
Accession:
GSE6532
ID:
200006532
6.

Metastatic breast cancer to the brain: implications of the local microenvironment for colonization and treatment

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8128
101 Samples
Download data
Series
Accession:
GSE14690
ID:
200014690
7.

Metastatic breast cancer to the brain: set 2

(Submitter supplied) Background: Metastases to the brain from breast cancer have a high mortality. Basal-like and HER2 positive breast cancers appear to have a high propensity to spread to the brain. The mechanisms that allow cells to colonise the brain are unclear. Methods: We have analysed matched and unpaired samples of breast cancer and brain metastases using morphology, immunophenotype and expression profiling and validated the data using in vitro cell culturing models and in vivo mice model. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8128
41 Samples
Download data
Series
Accession:
GSE14683
ID:
200014683
8.

Metastatic breast cancer to the brain: set 1

(Submitter supplied) Background: Metastases to the brain from breast cancer have a high mortality. Basal-like and HER2 positive breast cancers appear to have a high propensity to spread to the brain. The mechanisms that allow cells to colonise the brain are unclear. Methods: We have analysed matched and unpaired samples of breast cancer and brain metastases using morphology, immunophenotype and expression profiling and validated the data using in vitro cell culturing models and in vivo mice model. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8128
60 Samples
Download data
Series
Accession:
GSE14682
ID:
200014682
9.

Affymetrix SNP array analysis of the breast cell lines MCF10A, MCF10AT, MCF10CA1h and MCF10CA1a

(Submitter supplied) To characterize genomic instability in breast cancer progression, we examined copy number loss and copy number gain in the MCF10A series of cell lines.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platforms:
GPL3720 GPL3718
8 Samples
Download data: CEL, TXT
Series
Accession:
GSE19920
ID:
200019920
10.

Affymetrix SNP array data for mammary tumors that recurred after inactivation of the oncogenic PIK3CA-H1047R

(Submitter supplied) Gain-of-function mutation of PIK3CA represents one of the most common oncogenic events in human malignancy, making PI3K an attractive target for cancer therapy. Despite the great promise of targeted therapy, drug resistance is likely to develop, causing treatment failure. To elucidate resistance mechanisms to PI3K-targeted therapy, we constructed a mouse model of breast cancer conditionally expressing PIK3CA-H1047R. more...
Organism:
Mus musculus
Type:
Genome variation profiling by SNP array
Platform:
GPL13147
7 Samples
Download data: CEL
Series
Accession:
GSE27691
ID:
200027691
11.

Identification of novel gene amplification events in breast cancer

(Submitter supplied) To identify novel gene amplification events that may contribute to breast cancer progression, we examined copy number variation in 161 primary breast cancer samples using the Affymetrix 250K_Nsp and 250K_Sty microarrays or the Affymetrix SNP5.0 microarray.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; SNP genotyping by SNP array
Platforms:
GPL3718 GPL6804 GPL3720
203 Samples
Download data: CEL, CHP
Series
Accession:
GSE16619
ID:
200016619
12.

A functional genomics process for systematic dissection and mutation-specific target discovery in breast cancer PIK3CA hotspot mutations [CRISPR KO Screen Data]

(Submitter supplied) Despite the general understanding that different mutations impart different phenotypic changes within a cell, the majority of targeted therapies in cancer treatment are used to treat all mutations in the same gene regardless of location or phenotypic effects. There is a significant unmet need to distinguish distinct changes in cellular signaling which may provide opportunities for mutation-specific treatment with reduced toxicity to patients. more...
Organism:
Homo sapiens
Type:
Other
Platform:
GPL24676
6 Samples
Download data: CSV, TXT
Series
Accession:
GSE248041
ID:
200248041
13.

A functional genomics process for systematic dissection and mutation-specific target discovery in breast cancer PIK3CA hotspot mutations

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24676
21 Samples
Download data
Series
Accession:
GSE247822
ID:
200247822
14.

A functional genomics process for systematic dissection and mutation-specific target discovery in breast cancer PIK3CA hotspot mutations [ATAC-Seq]

(Submitter supplied) Despite the general understanding that different mutations impart different phenotypic changes within a cell, the majority of targeted therapies in cancer treatment are used to treat all mutations in the same gene regardless of location or phenotypic effects. There is a significant unmet need to distinguish distinct changes in cellular signaling which may provide opportunities for mutation-specific treatment with reduced toxicity to patients. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24676
6 Samples
Download data: NARROWPEAK
Series
Accession:
GSE247821
ID:
200247821
15.

A functional genomics process for systematic dissection and mutation-specific target discovery in breast cancer PIK3CA hotspot mutations [RNA-seq]

(Submitter supplied) Despite the general understanding that different mutations impart different phenotypic changes within a cell, the majority of targeted therapies in cancer treatment are used to treat all mutations in the same gene regardless of location or phenotypic effects. There is a significant unmet need to distinguish distinct changes in cellular signaling which may provide opportunities for mutation-specific treatment with reduced toxicity to patients. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
9 Samples
Download data: TXT
Series
Accession:
GSE247819
ID:
200247819
16.

Cdh1 and Pik3ca mutations cooperate to induce Immune-Related Invasive Lobular Carcinoma of the Breast

(Submitter supplied) CDH1 and PIK3CA are the two most frequently mutated genes in Invasive Lobular Carcinoma (ILC) of the breast. Transcription profiling has identified molecular subtypes for ILC, one of which - Immune-Related (IR) - is associated with gene expression linked to lymphocyte and macrophage infiltration. Here we report that homozygous deletion of Cdh1 together with mutational activation of Pik3ca in mammary epithelium of genetically modified mice leads to rapid formation of IR-ILC-like tumors with immune cell infiltration, as well as gene expression signatures linked to TRegulatory (Treg) cell signaling and immune checkpoint inhibitor pathway activation. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL24315
10 Samples
Download data: TXT
Series
Accession:
GSE107432
ID:
200107432
17.

Differential allelic expression in normal breast tissue

(Submitter supplied) Most loci contributing to breast cancer susceptibility identified by the recent genome-wide association studies (GWAS) are predicted to have a regulatory function. Additionally, the early phases of the GWAS studies have generated long lists of possible candidates that need to be prioritised for follow-up studies. Integration of allelic expression mapping and disease association data should enable the identification of those GWAS hits with higher cis-regulatory potential. more...
Organism:
Homo sapiens
Type:
Other
Platform:
GPL6988
130 Samples
Download data: TXT
Series
Accession:
GSE35023
ID:
200035023
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=4|qty=3|blobid=MCID_6697342a8e4788294a45c6fe|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center